Price movement over the last 24 hours
ADMA Biologics Inc vs eBay Inc — how do they compare? ADMA Biologics Inc trades at $9.2 (market cap $2.13B), while eBay Inc trades at $113.7 (market cap $50.94B). The key difference: eBay Inc is far larger — about 23.9× ADMA Biologics Inc's market cap, and eBay Inc pays a 1.08% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | EBAY | |
|---|---|---|
Market Cap | $2.13B | $50.94B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $118.96 |
52-Week Low | $7.60 | $75.33 |
Enterprise Value | $2.20B | $54.28B |
Volume | — | 5,186,418 |
Dividend Yield | — | 1.08% |
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
EBAY trades at $114.71, down slightly by 0.11% today. The stock shows strong profitability with a 17.61% net income margin and has beaten earnings estimates for three consecutive quarters. Technical indicators are bullish, with the price above key moving averages. Recent news highlights GameStop's unsolicited takeover interest, adding speculative momentum. Cash flow turned negative in 2025 but is projected to recover in 2026.
The outlook is mixed: solid fundamentals and earnings beats support upside, but the stock trades above the analyst consensus target of $109.50. Risks include takeover uncertainty and competitive pressures. Wall Street sentiment is neutral with a slight buy bias, though valuation multiples like P/E of 26.25 suggest limited near-term growth potential.
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →